Skip to main content
Fig. 2 | Biomarker Research

Fig. 2

From: The predictive value of tumor mutation burden for immune checkpoint inhibitors therapy in non-small cell lung cancer is affected by patients’ age

Fig. 2

Kaplan–Meier curves and HR analysis of the association between TMB and PFS in young and elderly patients in NSCLC. Kaplan–Meier curves of (a) Agelow group and (b) Agehigh group in Rizvi cohort, (c) Agelow group and (d) Agehigh group in Hellmann cohort. HR: hazard ratio; TMB: tumor mutation burden; PFS: progression-free survival; NSCLC: non-small cell lung cancer; CI: confidence interval

Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us